Clinicians' attitude towards changes in Australian National Cervical Screening Program

J Clin Virol. 2016 Mar:76 Suppl 1:S81-S87. doi: 10.1016/j.jcv.2015.11.018. Epub 2015 Nov 19.

Abstract

Background: Australian guidelines for cervical cancer screening are being revised under the "renewal program". Physicians' willingness to accept these changes will play a pivotal role in its success.

Objective: To understand the willingness and acceptance of, as well as barriers and facilitators for Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) affiliates to screening using human papillomavirus (HPV) testing, starting at 25 years of age, every 5 years.

Study design: An electronic survey of RANZCOG affiliates was undertaken April-June 2014, while renew was announced April 28th 2014. Responses used a 7 point Likert scale, which was dichotomized as ≤4, indicating 'unwilling' and >4, indicating 'willing' to adopt revised practices.

Results: Response rate was 22% (n=956): 60% were obstetricians and gynaecologists (OG); 27% general practitioner diplomates; 13% OG trainees. Overall, 60% (n=526/874) were willing to revise their screening practice. This correlated with awareness of new guidelines (p=<0.001). Fifty percent (n=438/869) of respondents were concerned about delaying to 25 years, and 48% (n=421/869) concerned cervical cancers would be missed. Reasons respondents gave for wishing to continue screening from 18 years contrary to guidelines included: women not being vaccinated (65.6%), immunosuppressed women (92.2%) and women who had been victims of childhood sexual assault (73.9%).

Conclusions: The majority of RANZCOG affiliates were willing to change screening practice however, a number of barriers to delaying onset of screening age to age 25 years were reported. Effective change management strategies will need to be implemented to address the concerns raised to ensure best practice for cervical screening.

Keywords: Cervical screening; Change management; Gynecologist; HPV testing; Human papillomavirus; Obstetrician; RANZCOG; Renew guidelines.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Age Factors
  • Australia
  • Early Detection of Cancer / methods
  • Female
  • Health Knowledge, Attitudes, Practice*
  • Human Papillomavirus DNA Tests
  • Humans
  • Mass Screening / legislation & jurisprudence
  • Mass Screening / psychology*
  • Papillomaviridae / classification
  • Papillomaviridae / genetics
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / diagnosis
  • Papillomavirus Infections / prevention & control
  • Papillomavirus Infections / psychology*
  • Papillomavirus Vaccines / administration & dosage
  • Physicians / psychology*
  • Practice Guidelines as Topic
  • Surveys and Questionnaires
  • Uterine Cervical Dysplasia / complications
  • Uterine Cervical Dysplasia / diagnosis
  • Uterine Cervical Dysplasia / prevention & control
  • Uterine Cervical Dysplasia / psychology*
  • Uterine Cervical Neoplasms / complications
  • Uterine Cervical Neoplasms / diagnosis
  • Uterine Cervical Neoplasms / prevention & control
  • Uterine Cervical Neoplasms / psychology*
  • Vaccination / psychology

Substances

  • Papillomavirus Vaccines